Glenmark Pharmaceuticals Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Small Cap

Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (U.S. FDA) for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), determined by the FDA to be bioequivalent1 to Advil®2 Dual Action with Acetaminophen Tablets, 250 mg/125 mg (OTC), of Haleon US Holdings, LLC.

Glenmark's Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the U.S. by Glenmark Therapeutics Inc., USA.

According to Nielsen® syndicated data for the latest 52 weeks period ending 23 March 2024, the Advil® Dual Action with Acetaminophen Tablets, 250 mg/125 mg (OTC) market achieved annual sales of approximately $84.1 million*.

Powered by Capital Market - Live News

Glenmark Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting at Rs 1013.7, up 0.77% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.09% on the day, quoting at 22493.7. The Sensex is at 74161.32, down 0.09%. Glenmark Pharmaceuticals Ltd has added around 9.42% in last one month.

Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has added around 0.35% in last one month and is currently quoting at 19125.2, up 0.43% on the day. The volume in the stock stood at 2.93 lakh shares today, compared to the daily average of 10.33 lakh shares in last one month.

The benchmark April futures contract for the stock is quoting at Rs 1016.3, up 0.72% on the day. Glenmark Pharmaceuticals Ltd is up 110.27% in last one year as compared to a 27.81% gain in NIFTY and a 56.49% gain in the Nifty Pharma index.

The PE of the stock is 26.98 based on TTM earnings ending December 23.

Powered by Capital Market - Live News

Glenmark Pharmaceuticals announced that Sridhar Gorthi (DIN: 00035824), Devendra Raj Mehta (DIN: 01067895), Brian Tempest (DIN: 00101235) and Bernard Munos (DIN: 05198283) have retired as Independent Directors of the Company from end of the day on 31 March 2024, consequent to the completion of their second term of office as Independent Directors.

Powered by Capital Market - Live News

Glenmark Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting at Rs 959.85, up 0.28% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.7% on the day, quoting at 22159.1. The Sensex is at 73016.66, up 0.75%. Glenmark Pharmaceuticals Ltd has added around 5.34% in last one month.

Meanwhile, Nifty Pharma index of which Glenmark Pharmaceuticals Ltd is a constituent, has added around 0.35% in last one month and is currently quoting at 18809.45, up 0.35% on the day. The volume in the stock stood at 4.74 lakh shares today, compared to the daily average of 10.46 lakh shares in last one month.

The benchmark March futures contract for the stock is quoting at Rs 960.35, up 0.35% on the day. Glenmark Pharmaceuticals Ltd is up 113.51% in last one year as compared to a 30.72% gain in NIFTY and a 58.98% gain in the Nifty Pharma index.

The PE of the stock is 25.63 based on TTM earnings ending December 23.

Powered by Capital Market - Live News